More BCAL Diagnostics Limited news
BCAL Diagnostics LimitedASX: BDX

Investor Presentation

Mar 24, 2025 at 12:07 AM EDT · Issued by BCAL Diagnostics Limited

Filed with ASX · Mar 24, 2025 at 12:07 AM EDT

On 6ix: 6ix.com/news/investor-presentation-384

Bcal Diagnostics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

BCAL Diagnostics Limited on 6ix

In the deck

  • Bcal Diagnostics — Investor Presentation (March 2025)32 slidesMar 24, 2025

Earlier from BCAL Diagnostics

  • BCAL Launches Breastest Plus Generating First RevenuesMar 23, 2025
  • NATA Accreditation ClarificationDec 12, 2024
  • BCAL Diagnostics Receives NATA AccreditationDec 11, 2024
  • Appendix 4E and Annual Report to ShareholdersAug 30, 2024
  • BCAL Commences US OperationsAug 28, 2024

Later from BCAL Diagnostics

  • Commercial Partnership with Cancer Care AssociatesJul 2, 2025
  • BCAL Partners with Sonic HealthcareAug 26, 2025
  • Appendix 4E and Annual ReportAug 29, 2025
  • BCAL and ClearNote Partner on Early Cancer Detection TestsSep 18, 2025
  • BCAL Establishes $10 million Convertible Note FacilityOct 19, 2025
All BCAL Diagnostics news releases↗

Follow BCAL Diagnostics into a list and get an email when it puts out news.

Follow BCAL Diagnostics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer